2016 ADX
2016 ADX Banner
  • About the Summit

About The Summit

Next Generation Dx Summit convenes more than 1,000 international diagnostic professionals for valuable networking and comprehensive programming spanning from clinical diagnostics to business strategy. Now in its eighth year, the event has grown to include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, commercialization, and reimbursement.  New programming in 2016 includes prenatal diagnostics, circulating tumor cells, forensics and microbiome sequencing. The Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important issues for the industry.

Conference Programs


Attendee Testimonials

“A concentrated event with more KOLs in attendance than any other conference I have been to.”
CEO, Raindance Technologies

"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursuing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences

"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline

"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH

View More Attendee Quotes



ADX-Prospectus Thumbnail2016 Prospectus Now Available.

Reserve your space early and SAVE!


Keynote Presentation: Implementing President Obama’s Precision Medicine Plan at the FDA, and Changing the Current Paradigm to Make Use of Targeted Studies Involving a Patient’s Specific Genetics, Health History and Lifestyle

Elizabeth MansfieldElizabeth A. Mansfield, Ph.D., Director, Personalized Medicine, Office of In Vitro Diagnostics & Radiological Health, FDA CDRH

Disruptive Innovation in Laboratory Medicine: Game-Changing Technologies and Approaches

Ted SchutzbankModerator: Ted E. Schutzbank, Ph.D., D(ABMM), Technical Director, Specialized Testing and Microbiology, Laboratory Services, St. John Providence Health System


Rebecca McClure, M.D., Senior Scientist, Pathology, Health Sciences North/Horizon Santé-Nord

Dan Snyder, President & CEO, Molecular MD

Steven Kafka, Ph.D., President, Foundation Medicine

Charles Mathews, Vice President, Boston Healthcare


Stories and Videos from Next Generation Dx Summit 2015


Cross-Industry Diagnostic Experts Discuss Balancing Innovation & Regulation

2015 PAMA Update: Impact on Molecular Tests

Next Generation Dx Summit 2015 Exhibitor Testimonials


Event Features

  • Form partnerships with major players in the evolving areas of diagnostics
  • Gain a comprehensive up-to-date view of diagnostics
  • Gather important industry announcements 
  • Network with 1,000+ attendees from around the world
  • Hear late-breaking news on regulation and disruptive technologies in the plenary session
  • Connect with attendees using CHI’s Intro-Net
  • Review latest technologies in the poster competition
  • Choose from a range of in-depth short courses with topic experts
  • View innovative products and novel platforms in the exhibit hall

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Final Days to Register

2016 Brochure

2016 Next Generation Dx Summit Brochure

ADX 2016 CAG Brochure Icon

Premier Sponsors


Positive ID

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products